Analysis of prognostic factors in patients with locally advanced cervical squamous cell carcinoma and development of a nomogram prediction model
The authors developed a prognostic nomogram that predicts 3-, 4-, and 5-year overall survival in patients with locally advanced cervical squamous cell carcinoma (LACSC).
A prognostic nomogram integrating clinical and laboratory variables was developed and validated to predict 3-, 4-, and 5-year overall survival for patients with locally advanced cervical squamous cell carcinoma.
Reliable prognostic tools enable clinicians to stratify risk, personalize treatment, and improve decision‑making for LACSC patients.
Bizonyítékszint: Korai humán adat. Kis vagy feltáró emberi adat.
Kapcsolódó jelek
- Quercetin suppresses the progression of HBV-associated hepatocellular carcinoma by modulating the EGFR signaling pathway
- Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial
- Surgical treatment of hepatocellular carcinoma: expert consensus statement
- Loco-regional treatment of hepatocellular carcinoma
- Real‑World Outcomes of Atezolizumab‑Bevacizumab in Hepatocellular Carcinoma: The Prospective French CHIEF Cohort